| 核心竞争力愈显突出。公司股价受市场等诸多因素影 | | --- | | 响，未来公司将持续做好经营业务，努力提高经营业 | | 绩，不断提升公司价值。谢谢！ | | 2.公司自重组以来股价持续下跌，公司持股 70% | | 回购股票不太可能。那么有没有计划注销部分公司持 | | 股以确保中小投资者权益。 | | 您好！公司目前没有回购注销部分公司股票的计 | | 划，若后续有相关安排,将及时履行信息披露义务。 | | 谢谢！ | | 3.领导，您好！我来自四川大决策 请简单介绍 | | 一下目前公司在风电、光伏发展情况？ | | 您好！截至 2025 年 4 月 17 日，公司累计已投产 | | 发电的清洁能源项目总装机 4430.68MW，其中水力发 | | 电 380.5MW ，风力发电 800.36MW ，光伏发电 | | 3149.82MW，独立储能 100MW。谢谢！ | | 4.在目前行业竞争激烈的环境下，公司计划如何 | | 扩大市场份额 | | 您好！公司将充分发挥四类五项工程施工特级资 | | 质优势，重点关注广东省内交通、水利、市政等方面 | | 基础设施项目，积极推进广东省外市场布局 ...

Financial Performance - In 2024, the company achieved a revenue of CNY 12.518 billion, with a net profit of CNY 484 million, representing a year-on-year decline of 74.40% [2] - For Q1 2025, the company reported a revenue of CNY 3.489 billion, with a net profit of CNY 149 million, showing a year-on-year growth of 30.8% [2] - The core product, electrolyte sales, exceeded 500,000 tons in 2024, marking a year-on-year increase of approximately 26% compared to 2023 [2] Market and Competitive Landscape - The company maintains a competitive advantage despite challenges such as declining product prices and unit profitability due to raw material price fluctuations and intensified competition [3] - The demand from downstream industries is expected to increase in 2025, leading to improved supply-demand balance and a healthier competitive landscape [3] Strategic Initiatives - The impact of U.S. tariffs on the company is minimal, with only about 1% of total revenue derived from direct sales to the U.S. [3] - The company is actively pursuing local production capacity in the U.S. in collaboration with Honeywell, with plans for a 200,000-ton annual production facility for electrolytes in Texas [3] Product Development and Innovations - The LIFSI additive in electrolytes is projected to increase from 1.9% in 2024, driven by its superior performance in fast-charging battery formulations [3] - The company is advancing its PEEK materials, currently in trial production, with applications in robotics and chemical industries [4] - A new 5V electrolyte system was launched in March, targeting applications in power batteries and energy storage systems [4] - Development of solid and semi-solid electrolytes is ongoing, with a focus on lithium sulfide routes [4] Cost Management and Production Capacity - The company has a production capacity of 330,000 tons for iron phosphate, benefiting from an integrated layout and scale effects to reduce costs [4] - Future capital expenditures will be controlled, with a focus on international market expansion as domestic capacity growth slows [5]

机构调研纪要 | 会议目的 | 2025 年 4 月 23 | 日行业分析师及机构投资者交流纪要 | | | | | | --- | --- | --- | --- | --- | --- | --- | | 参加人 | 交流机构 | 开源证券 | 长江证券 | 西南证券 | 华创证券 | | | | | 东北证券 | 华西证券 | 申万宏源 | 东吴证券 | | | | | 国投证券 | 中信证券 | 华福证券 | 国信证券 | | | | | 上海证券 | 太平洋证券 | 长城证券 | 方正证券 | | | | | 广发证券 | 中泰证券 | 中信建投证券 | 招商证券 | | | | | 国元证券 | 信达证券 | 红塔证券 | 华安证券 | | | | | 中银基金 | 中天汇富基金 | 银华基金 | 泉果基金 | | | | | 华夏未来资本 | 圆石投资 | 玖鹏资产 | | 耕霁(上海)投资 | | | | IGWT Investment 合道资产 姜桂宾 | 董事长 | | 从容投资 | 三登投资 | | | | 贺文涛 | 董事、总经理 | | | | | | 英搏尔 | 梁小天 | 董事、 ...

编号：2025-001 | 投资者关系活 | □媒体采访  | 业绩说明会 | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 动类别 | □新闻发布会  | | | | | | 路演活动 | | | □现场参观 开源证券 长江证券 西南证券 | | | 华创证券 | | | | | | 东北证券 华西证券 申万宏源 | | | 东吴证券 | | | | | | 国投证券 中信证券 华福证券 | | | 国信证券 | | | | | | 上海证券 太平洋证券 长城证券 | | 方正证券 | | | | | | | 国元证券 信达证券 红塔证券 | | | 华安证券 | | | | | | 中银基金 中天汇富基金 银华基金 | | | | 泉果基金 | | | | | 华夏未来资本 圆石投资 玖鹏资产 | | | | | 耕霁(上海)投资 | | | | IGWT Investment 合道资产 | 从容投资 | | | | 三登投资 | | | 时间 | 2025 年 4 月 23 日 | | | | | | | | 地点 | 网 ...

Group 1: Economic Outlook - The macroeconomic environment in 2024 faces multiple downward pressures, but recent policies have stabilized the economy, with GDP growth targets expected to be met [1] - The government plans to implement more proactive macro policies in 2025 to stabilize the real estate and stock markets [2] - High-quality economic growth in 2025 will be driven by breakthroughs in frontier technologies [2] Group 2: Real Estate Policy - The government has introduced policies to stabilize the real estate market, including measures to control new construction and optimize existing stock [2] - The emphasis on "good housing" construction and the release of market potential are key focuses for 2025 [2] - Recent policies have sent strong signals for stabilizing the real estate market, with expectations for more supportive measures to be implemented [2] Group 3: Market Performance - In Q1 2025, new housing sales volume and prices in 100 cities showed a slight year-on-year decline, but the rate of decline has narrowed significantly [3] - Major cities like Beijing, Shanghai, and Shenzhen have seen significant price increases, with a 20% year-on-year rise in second-hand home transactions in 30 key cities [3] - The land market has shown signs of recovery, with significant land price increases in cities like Hangzhou and Shanghai, indicating a positive trend ahead of residential sales [3] Group 4: Company Strategy - The company will maintain its strategic focus on core cities and sectors, ensuring cash flow safety while pursuing high-quality development [4] - The real estate sector is expected to stabilize at an industry scale of 8-10 trillion yuan, with the company committed to enhancing product quality and operational capabilities [4] - The company aims to strengthen its asset management capabilities, focusing on commercial, industrial, and residential properties, with a significant number of projects entering operation [4] Group 5: Financial Strategy - The company plans to develop a new financing model tailored to the characteristics of different business segments, ensuring a robust capital structure [5] - Continuous cost reduction and efficiency improvements are prioritized to maintain industry-leading capital structure and optimal funding costs [5]

广东朝阳电子科技股份有限公司 投资者关系活动记录表 编号：2025-001 请以公司在指定媒体披露的定期报告为准。感谢您的关注。 2.在信息披露方面如何确保真实、准确、完整、及时，如 何提高信息披露的质量和透明度，增强投资者对公司的信心？ 证券代码：002981 证券简称：朝阳科技 投资者关系 活动类别 ☐特定对象调研 ☐分析师会议 ☐媒体采访 业绩说明会 ☐新闻发布会 ☐路演活动 ☐现场参观 ☐其他 参与单位名 称及人员姓 名 线上参与公司2024年度网上业绩说明会的全体投资者 时间 2025年4月23日 15:30-17:00 地点 价值在线（https://www.ir-online.cn/） 上市公司接 待人员姓名 董事长兼总经理 郭丽勤女士 独立董事 谌龙先生 董事会秘书 袁宏女士 财务总监 龚峰先生 投资者关系 活动主要内 容介绍 互动交流环节具体内容如下： 1.公司产品约40%销往美国，请问关税对朝阳科技的影响， 公司怎么应对？ 答:尊敬的投资者，您好。当前国际贸易形势存在较大不确 定性，公司将持续关注国际贸易政策动态，积极与客户和商业 合作伙伴保持密切沟通，努力降低外部因素对公司业务的潜在 影 ...

证券代码：001914 证券简称：招商积余 招商局积余产业运营服务股份有限公司 招商局集团上市公司集体业绩说明会活动记录表 | 投资者关系活动 | 业绩说明会 | | --- | --- | | 类别 | | | 参与单位名称及 | 现场及网络直播，面向所有投资者 | | 人员姓名 | | | 时间 | 年 月 日 2025 4 23 14:30-16:40 | | 地点 | 深圳证券交易所上市大厅；线上直播平台：互动易、全景网 | | 上市公司接待人 员姓名 | 招商蛇口副总经理、招商积余董事长吕斌，招商积余董事总经理 | | | 陈智恒、独立董事邹平学、财务总监江霞、董事会秘书陈江 | | | 一、业绩介绍 | | | 公司董事长吕斌对招商积余主要财务指标、2024 年经营情 | | | 况和 年发展展望进行了介绍。 2025 | | | 二、互动交流 | | | 【问题 1】公司非住宅业态里具体哪个业态具备领先优势以 | | | 及未来如何保持领先优势？住宅这个领域公司去年取得了一定 | | | 突破，未来到 年是否会持续增长？ 2025 | | 投资者关系活动 | 【回答】首先回答第一个问题。2024 ...

Group 1: Company Overview and Performance - The company focuses on comprehensive medical services, primarily relying on local health insurance bureaus for revenue settlement [4] - Despite an increase in outpatient and inpatient volumes in 2024, the company's operating performance has declined due to adjustments in health insurance settlement policies, leading to reduced service charges and lower gross margins [4] - The company has invested in innovative projects such as brain-computer interfaces (BCI) and AI medical models to enhance traditional medical services [4] Group 2: AI Medical Model Development - The AI medical model currently collaborates with approximately 60 hospitals in 2024, with an expected increase of about 100 hospitals in 2025 [6] - Projected revenue for the AI medical model is estimated at 4.4 million in 2024 and aims for 40 million in 2025 [6] - The AI model has shown significant cost reduction and efficiency improvement in hospitals, particularly through features like in-clinic dictation and inpatient dictation [6] Group 3: BCI Product Development - The BCI product assists stroke patients in regaining control over their upper limb movements, enabling basic daily activities [7] - The BCI product can operate for approximately 6 hours on a single charge, with a replaceable battery [8] - The BCI product is undergoing multi-center clinical trials and is expected to complete registration for medical device classification by mid-2026 [8] Group 4: Market Impact and Financial Projections - The BCI product is anticipated to significantly reduce rehabilitation costs for patients, allowing families to save between 40,000 to 60,000 annually by replacing full-time caregivers with part-time help [10] - The pricing strategy for the BCI product is based on the value it provides to stroke patients, with specific pricing details to be announced upon launch [10]

Financial Performance - In 2024, the company achieved operating revenue of 2.55 billion, a year-on-year increase of 2.6% [2] - The net profit attributable to shareholders reached 787 million, up 9.8%, with a profit growth rate exceeding revenue growth by 7.2 percentage points [2] - Excluding the salt lake lithium extraction project, the core business revenue was 2.46 billion, a 25% increase, accounting for 96.1% of total revenue [2] - The comprehensive gross profit margin for 2024 was 49.5%, remaining stable compared to the previous year [2] Q1 2025 Performance - In Q1 2025, the company reported revenue of 577 million, a decrease of 8% year-on-year, but net profit attributable to shareholders increased by 1.93% [2][3] - Excluding the salt lake lithium project, core business revenue in Q1 2025 was 577 million, reflecting a 9% year-on-year growth [3] Project Revenue Recognition - In Q1 2024, the company recognized approximately 99 million in revenue from the Guotou Luokai project [4] - Revenue from ongoing salt lake lithium projects will be recognized based on project progress and fulfillment of contractual obligations [4] Life Sciences Sector - The company has expanded production capacity in the life sciences sector, achieving capacities of 120 tons and 70,000 liters for solid-phase carriers and agarose/dextran respectively [5] - Plans are in place to establish a new GMP-grade production facility and an independent life sciences park to enhance product quality and stability [5] Domestic and International Market Strategy - The company achieved overseas sales revenue of 655 million, a significant increase of 45.1% year-on-year, outpacing domestic growth [10] - The internationalization strategy has been a key competitive advantage, with a focus on expanding into North America, Europe, Asia, South America, and Africa [10] - In 2024, the company established a wholly-owned subsidiary in the U.S. and set up storage units in North America and Europe to enhance operational efficiency [10] Technological Advancements - The company has achieved effective domestic substitution in various fields, including cephalosporin production and gallium extraction, leveraging proprietary adsorption technology [6] - The demand for solid-phase synthesis carriers is driven by the significant growth in GLP-1 peptide drug sales, maintaining a high market share [7] - The company is actively innovating in energy-saving and environmental protection technologies, with stable sales trends in CO2 capture and wastewater treatment products [9]

云南恩捷新材料股份有限公司 投资者关系活动记录表 证券代码：002812 证券简称：恩捷股份 债券代码：128095 债券简称：恩捷转债 编号：2025-002 | | □特定对象调研 □分析师会议 | | | --- | --- | --- | | 投资者关系 | □媒体采访 ☑业绩说明会 | | | 活动类别 | □新闻发布会 □路演活动 | | | | □现场参观 | | | | □其他 | | | 参与单位名 | 通过全景网"投资者关系互动平台"（http://ir.p5w.net）参与公司 2024 年度业绩说明 | | | 称及人员姓 | 会的广大投资者 | | | 名 | | | | 时间 | 年 月 日 4 23 | 2025 | | 地点 | 全景网"投资者关系互动平台"（http://ir.p5w.net） | | | 上市公司接 | 董事长 Paul Xiaoming Lee、副董事长兼总经理李晓华、副总经理兼董事会秘书禹 | | | 待人员姓名 | 雪、财务总监李见、独立董事张菁 | | | | 公司就投资者以下问题进行回复： | | | | 1、请问公司还有计划在国内继续扩产锂电池隔 ...